CSIMarket
 

Beta Bionics Inc   (NASDAQ: BBNX)

Beta Bionics Inc 's

Competitiveness




 

BBNX Sales vs. its Competitors Q2 2026







Revenue Growth Comparisons




Net Income Comparison




<<  BBNX Stock Performance Comparisons


Beta Bionics Inc 's Comment on Competition and Industry Peers


The competitive landscape includes competing with other treatment options based on availability, perceived advantages, relative cost, safety, and effectiveness. Emerging competing technologies and adverse market developments necessitate enhancements to existing products or the development of new products to maintain market share. Competition also influences patient enrollment in clinical trials, as patients may opt to participate in trials of competitor products. Additionally, regulatory pathways and potential third-party actions can affect the timing and approval of product candidates, impacting competitive positioning.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Beta Bionics Inc



Sources: Beta Bionics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Beta Bionics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.